Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - Business Wire

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:30

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder  Business Wire